These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32852713)

  • 1. Ovariectomized rodents as a menopausal metabolic syndrome model. A minireview.
    Medina-Contreras J; Villalobos-Molina R; Zarain-Herzberg A; Balderas-Villalobos J
    Mol Cell Biochem; 2020 Dec; 475(1-2):261-276. PubMed ID: 32852713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic syndrome and visceral fat in women with cardiovascular risk factor].
    Soto Rodríguez A; García Soidán JL; Arias Gómez MJ; Leirós Rodríguez R; Del Álamo Alonso A; Pérez Fernández MR
    Nutr Hosp; 2017 Jul; 34(4):863-868. PubMed ID: 29095010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet.
    Buniam J; Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Saengsirisuwan V
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E908-E921. PubMed ID: 30807216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovariectomy-Induced Hepatic Lipid and Cytochrome P450 Dysmetabolism Precedes Serum Dyslipidemia.
    Malinská H; Hüttl M; Miklánková D; Trnovská J; Zapletalová I; Poruba M; Marková I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk.
    Villasante Fricke AC; Iacobellis G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study.
    Abdulnour J; Doucet E; Brochu M; Lavoie JM; Strychar I; Rabasa-Lhoret R; Prud'homme D
    Menopause; 2012 Jul; 19(7):760-7. PubMed ID: 22395454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome During Menopause.
    Mumusoglu S; Yildiz BO
    Curr Vasc Pharmacol; 2019; 17(6):595-603. PubMed ID: 30179134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.
    Ragino YI; Stakhneva EM; Polonskaya YV; Kashtanova EV
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women.
    Fernández Muñoz MJ; Basurto Acevedo L; Córdova Pérez N; Vázquez Martínez AL; Tepach Gutiérrez N; Vega García S; Rocha Cruz A; Díaz Martínez A; Saucedo García R; Zárate Treviño A; González Escudero EA; Degollado Córdova JA
    Rev Esp Cardiol (Engl Ed); 2014 Jun; 67(6):436-41. PubMed ID: 24863591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effect of combined exercise training in a model of metabolic syndrome and menopause: autonomic, inflammatory, and oxidative stress evaluations.
    Conti FF; Brito Jde O; Bernardes N; Dias Dda S; Malfitano C; Morris M; Llesuy SF; Irigoyen MC; De Angelis K
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1532-9. PubMed ID: 26423710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).
    Panneerselvam S; Packirisamy RM; Bobby Z; Elizabeth Jacob S; Sridhar MG
    J Nutr Biochem; 2016 Dec; 38():57-69. PubMed ID: 27723468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial fat, metabolic dysregulation, and cardiovascular risk: putting things together.
    López-Jiménez F; Sochor O
    Rev Esp Cardiol (Engl Ed); 2014 Jun; 67(6):425-7. PubMed ID: 24863588
    [No Abstract]   [Full Text] [Related]  

  • 13. The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men.
    Fujibayashi K; Gunji T; Yokokawa H; Naito T; Sasabe N; Okumura M; Iijima K; Shibuya K; Hisaoka T; Fukuda H
    PLoS One; 2016; 11(3):e0149689. PubMed ID: 26938785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms.
    Kase NG; Gretz Friedman E; Brodman M; Kang C; Gallagher EJ; LeRoith D
    Am J Obstet Gynecol; 2020 Dec; 223(6):820-833. PubMed ID: 32497614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease.
    Sironi AM; Petz R; De Marchi D; Buzzigoli E; Ciociaro D; Positano V; Lombardi M; Ferrannini E; Gastaldelli A
    Diabet Med; 2012 May; 29(5):622-7. PubMed ID: 22023514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5α-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
    Milutinović DV; Nikolić M; Veličković N; Djordjevic A; Bursać B; Nestorov J; Teofilović A; Antić IB; Macut JB; Zidane AS; Matić G; Macut D
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):522-529. PubMed ID: 28407665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.
    Mathieu P; Boulanger MC; Després JP
    Rev Endocr Metab Disord; 2014 Dec; 15(4):289-98. PubMed ID: 25326657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
    Lord J; Thomas R; Fox B; Acharya U; Wilkin T
    BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis.
    Matsuda M; Kawamoto T; Tamura R
    Obes Res Clin Pract; 2017; 11(1):34-43. PubMed ID: 26964726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.